Related references
Note: Only part of the references are listed.Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA)
Sally C. Inglis et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction.
Robert W. Yeh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Hazard Function and Secular Trends in the Risk of Recurrent Acute Myocardial Infarction 30 Years of Follow-Up of More Than 775 000 Incidents
Mats Gulliksson et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2009)
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
Roxana Mehran et al.
EUROPEAN HEART JOURNAL (2009)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Kenneth Dickstein et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Temporal decline in the prognostic impact of a recurrent acute myocardial infarction 1985 to 2002
P. Buch et al.
HEART (2007)
The. impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction
Peter A. Kavsak et al.
AMERICAN HEART JOURNAL (2006)
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction
S Orn et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Impact of the recommendations for the redefinition of myocardial infarction on diagnosis and prognosis in an unselected United Kingdom cohort with suspected cardiac chest pain
J Trevelyan et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction
NS Anavekar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction
SJ Kernis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Impact of the troponin standard on the prevalence of acute myocardial infarction
MC Kontos et al.
AMERICAN HEART JOURNAL (2003)
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
HR Andersen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
EC Keeley et al.
LANCET (2003)
Early reinfarction after fibrinolysis - Experience from the Global Utilization of Streptokinase and Tissue plasminogen activator (Alteplase) for occluded coronary arteries (GUSTO I) and Global Use of Strategies to Open occluded coronary arteries (GUSTO III) trials
MP Hudson et al.
CIRCULATION (2001)
Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results front the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction [MITRA], and the Myocardial Infarction Registry [MIR])
K Dönges et al.
AMERICAN JOURNAL OF CARDIOLOGY (2001)
Valsartan in Acute Myocardial Infarction trial (VALIANT): Rationale and design
MA Pfeffer et al.
AMERICAN HEART JOURNAL (2000)
Share Paper
